Search CMI

Note: the documents on this web site are PDF files. If you do not have a PDF reader, you can download one now.

Brand Name: the name given to the medicine by the company that makes the medicine. There may be more than one brand name if more than one company makes the medicine.

IMPORTANT INFORMATION

Reading the CMI does not take the place of counselling by a health professional. Always talk to your doctor or pharmacist about all aspects of your medicines, including why you are taking them and what benefits / risks you can expect.
The CMI for your medicine that is on this web site is the most up-to-date version available. It may differ from a CMI that you previously received from your doctor or pharmacist, or in your pack of medicine.

This web site does not contain all CMIs for medicines sold in Australia and not all medicines have a CMI available for them. If you do not find a CMI for your medicine on this page, contact the pharmaceutical company who makes the medicine or talk to your doctor or pharmacist. The information on this web site is intended for use in Australia only.

Product name	Date released
Temozolomide Alphapharm 04 May 2020   Temozolomide Alphapharm is used to treat patients with brain tumours. Temozolomide Alphapharm is also used to treat adult patients with advanced metastatic malignant melanoma. Your doctor, however, may prescribe Temozolomide Alphapharm for another purpose. This medicine belongs to a group of medicines called cytotoxic or chemotherapy medicines. It works by killing cancer cells and stopping cancer cells from growing and multiplying. Ask your doctor if you have any questions about why this medicine has been prescribed for you. This medicine is available only with a doctor's prescription. Temozolomide Alphapharm capsules are used to treat children 3 years and older, with specific forms of brain tumour (glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy). read more Download PDF Standard Print Download PDF Large Print
Tenofovir Disoproxil Emtricitabine Efavirenz Viatris 26 Apr 2024   Do not use if you have ever had an allergic reaction to tenofovir disoproxil maleate, emtricitabine and efavirenz or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use TENOFOVIR DISOPROXIL/EMTRICITABINE/EFAVIRENZ VIATRIS 300/200/600? in the full CMI. read more Download PDF Standard Print Download PDF Large Print Audio under revision, check back soon
Tenofovir Disoproxil Emtricitabine Viatris 02 Sep 2022   TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 is used to treat Human Immunodeficiency Virus (HIV) infection in adults. This medicine must be taken in combination with other anti-HIV medicines. TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 consists of two medicines: tenofovir disoproxil maleate emtricitabine These are combined in one tablet to help control Human Immunodeficiency Virus (HIV) infection. TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 contains two active ingredients that belong to a group of antiviral medicines known as nucleoside and nucleotide reverse transcriptase inhibitors (NRTI). TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 is used: to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults when taken in combination with other anti-HIV medicines; to help reduce the risk of getting HIV infection when used with safer sex practices in: HIV-negative men who have sex with men, who are at high risk of getting infected with HIV-1 through sex. Male-female sex partners when one partner has HIV-1 infection and the other does not. When TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 is used to treat HIV infection When used with other HIV-1 medicines to treat HIV-1 infection, TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 may help: Reduce the amount of HIV-1 in your blood. This is called “viral load”. Increase the number of CD4+ (T) cells in your blood that help fight off other infections. Reducing the amount of HIV-1 and increasing the CD4+ (T) cells in your blood may help improve your immune system. This may reduce your risk of death or infections that can happen when your immune system is weak. Use in Children and Elderly TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 is for adults. Do not take TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 if you are under the age of 18 years. Do not take TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 if you are over the age of 65 before discussing with your doctor. read more Download PDF Standard Print Download PDF Large Print
Tenofovir Disoproxil Viatris 23 Sep 2022   Tenofovir disoproxil maleate is an antiviral medication used to treat two different viruses; Chronic Hepatitis B (CHB) and Human Immunodeficiency Virus (HIV) infection. TENOFOVIR DISOPROXIL VIATRIS is a type of medicine called HBV polymerase inhibitor and a nucleotide analogue reverse transcriptase inhibitor (NRTI). How TENOFOVIR DISOPROXIL VIATRIS works in the Treatment of CHB: TENOFOVIR DISOPROXIL VIATRIS is used to treat CHB (an infection with hepatitis B virus [HBV]) in adults and paediatric patients aged 12 years and older and weighing at least 35 kg. TENOFOVIR DISOPROXIL VIATRIS works by interfering with the normal working of enzymes (HBV DNA polymerase) that are essential for HBV to reproduce itself. TENOFOVIR DISOPROXIL VIATRIS may help lower the amount of hepatitis B virus in your body by lowering the ability of the virus to multiply and infect new liver cells and can improve the inflammation and scar tissue caused by the hepatitis B virus in your liver. Lowering the amount of virus in your body may reduce the chance of developing cirrhosis, liver failure and liver cancer. We do not know how long TENOFOVIR DISOPROXIL VIATRIS may help treat your hepatitis. Sometimes viruses change in your body and medicines no longer work. This is called drug resistance. How TENOFOVIR DISOPROXIL VIATRIS works in the Treatment of HIV Infection: TENOFOVIR DISOPROXIL VIATRIS is also used to treat HIV infection in adults and paediatric patients aged 12 years and older and weighing at least 35 kg. TENOFOVIR DISOPROXIL VIATRIS is always used in combination with other anti-HIV medicines to treat people with HIV-1 infection. HIV infection destroys CD4 (T) cells, which are important to the immune system. After a large number of T cells are destroyed, acquired immune deficiency syndrome (AIDS) develops. TENOFOVIR DISOPROXIL VIATRIS helps to block HIV-1 reverse transcriptase, a chemical (enzyme) in your body that is needed for HIV-1 to multiply. TENOFOVIR DISOPROXIL VIATRIS lowers the amount of HIV-1 in the blood (called viral load) and may help to increase the number of T cells (called CD4 cells). Lowering the amount of HIV-1 in the blood lowers the chance of death or infections that happen when your immune system is weak (opportunistic infections). You do not have to have HIV infection to be treated with TENOFOVIR DISOPROXIL VIATRIS for HBV and vice versa. Use in Children TENOFOVIR DISOPROXIL VIATRIS is for adults and paediatric patients aged 12 years and older and weighing at least 35 kg. read more Download PDF Standard Print Download PDF Large Print
Tenormin 14 Jun 2022   Do not use if you have ever had an allergic reaction to TENORMIN or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use TENORMIN? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Tepmetko 20 Jun 2022   Do not use if you have ever had an allergic reaction to TEPMETKO or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to have a baby or are breastfeeding. For more information, see Section 2. What should I know before I use TEPMETKO? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Terimide 05 May 2022   Do not use if you have ever had an allergic reaction to teriflunomide or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use TERIMIDE? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Testavan 30 Aug 2022   Do not use if you have ever had an allergic reaction to testosterone, propylene glycol or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use TESTAVAN? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Tetrabenazine 17 Nov 2022   Do not take if you have ever had an allergic reaction to Tetrabenazine or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I take Tetrabenazine? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Tevatiapine XR 25 Jan 2022   Do not use if you have ever had an allergic reaction to quetiapine or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use TEVATIAPINE XR? in the full CMI. read more Download PDF Standard Print Download PDF Large Print

Second tab content goes here.